Literature DB >> 34057613

Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities.

Yuka Sugawara1, Masao Iwagami2,3, Yoko Yoshida1, Kan Kikuchi4, Ryoichi Ando5, Toshio Shinoda6, Munekazu Ryuzaki7, Hidetomo Nakamoto8, Ken Sakai9, Norio Hanafusa10, Naoki Kashihara11, Masaomi Nangaku12.   

Abstract

BACKGROUND: There are no reports of a large-scale survey on the infection prevention measures against coronavirus disease 2019 (COVID-19) in nephrology facilities. This study investigated the facility-level nephrology practices adopted during the COVID-19 pandemic and their associated challenges. Additionally, the treatment patterns and outcomes of chronic kidney disease (CKD) patients with COVID-19 were reviewed.
METHODS: We conducted a nationwide questionnaire survey of 704 educational facilities that were certified by the Japanese Society of Nephrology (JSN) from October 20, 2020 to November 16, 2020. The questionnaire reviewed the facility characteristics, infection prevention measures taken during routine nephrology practice, impact of COVID-19 on nephrology practice, experiences in managing CKD patients with COVID-19, and nosocomial transmission in the nephrology unit.
RESULTS: Of the 347 facilities that responded, 95.1% checked outpatients' body temperatures and COVID-19 symptoms at their visits. To reduce face-to-face contact, 80% and 70% of the facilities lengthened the intervals between outpatient visits and introduced online/telephonic consultations, respectively. As a result, more than half of the hospitals experienced a decrease in the numbers of outpatients and inpatients (64% and 50%, respectively). During the study period, 347 facilities managed 479 CKD patients with COVID-19. Oxygen administration and mechanical ventilation were performed for 47.8% and 16.5% of the patients, respectively, with a 9.2% total mortality rate.
CONCLUSION: This survey demonstrated that JSN-certified educational nephrology facilities adopted multiple measures to manage the COVID-19 pandemic; however, they faced several challenges. Sharing these experiences could standardize these approaches and prepare us better for the future.

Entities:  

Keywords:  COVID-19; Chronic kidney disease; Questionnaire survey; SARS-CoV-2

Year:  2021        PMID: 34057613     DOI: 10.1007/s10157-021-02082-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  9 in total

1.  Epidemiology of COVID-19 Outbreak in Japan, from January-March 2020.

Authors:  Yuki Furuse; Yura K Ko; Mayuko Saito; Yugo Shobugawa; Kazuaki Jindai; Tomoya Saito; Hiroshi Nishiura; Tomimasa Sunagawa; Motoi Suzuki; Hitoshi Oshitani
Journal:  Jpn J Infect Dis       Date:  2020-04-30       Impact factor: 1.362

2.  Admissions to Veterans Affairs Hospitals for Emergency Conditions During the COVID-19 Pandemic.

Authors:  Aaron Baum; Mark D Schwartz
Journal:  JAMA       Date:  2020-07-07       Impact factor: 56.272

3.  Chronic non-communicable diseases: a sacrifice on the altar of COVID-19?

Authors:  Philippe Domeyer; Vasiliki Katsari; Anargiros Mariolis
Journal:  Br J Gen Pract       Date:  2020-05-28       Impact factor: 5.386

Review 4.  Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.

Authors:  Adeera Levin; Marcello Tonelli; Joseph Bonventre; Josef Coresh; Jo-Ann Donner; Agnes B Fogo; Caroline S Fox; Ron T Gansevoort; Hiddo J L Heerspink; Meg Jardine; Bertram Kasiske; Anna Köttgen; Matthias Kretzler; Andrew S Levey; Valerie A Luyckx; Ravindra Mehta; Orson Moe; Gregorio Obrador; Neesh Pannu; Chirag R Parikh; Vlado Perkovic; Carol Pollock; Peter Stenvinkel; Katherine R Tuttle; David C Wheeler; Kai-Uwe Eckardt
Journal:  Lancet       Date:  2017-04-20       Impact factor: 79.321

5.  Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy.

Authors:  Ovidio De Filippo; Fabrizio D'Ascenzo; Filippo Angelini; Pier Paolo Bocchino; Federico Conrotto; Andrea Saglietto; Gioel Gabrio Secco; Gianluca Campo; Guglielmo Gallone; Roberto Verardi; Luca Gaido; Mario Iannaccone; Marcello Galvani; Fabrizio Ugo; Umberto Barbero; Vincenzo Infantino; Luca Olivotti; Marco Mennuni; Sebastiano Gili; Fabio Infusino; Matteo Vercellino; Ottavio Zucchetti; Gianni Casella; Massimo Giammaria; Giacomo Boccuzzi; Paolo Tolomeo; Baldassarre Doronzo; Gaetano Senatore; Walter Grosso Marra; Andrea Rognoni; Daniela Trabattoni; Luca Franchin; Andrea Borin; Francesco Bruno; Alessandro Galluzzo; Alfonso Gambino; Annamaria Nicolino; Alessandra Truffa Giachet; Gennaro Sardella; Francesco Fedele; Silvia Monticone; Antonio Montefusco; Pierluigi Omedè; Mauro Pennone; Giuseppe Patti; Massimo Mancone; Gaetano M De Ferrari
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

6.  Cohort profile: the chronic kidney disease prognosis consortium.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Brad C Astor; Paul E de Jong; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey; Adeera Levin; Chi-Pang Wen; Mark Woodward; Josef Coresh
Journal:  Int J Epidemiol       Date:  2012-12-12       Impact factor: 7.196

7.  New measures against chronic kidney diseases in Japan since 2018.

Authors:  Akira Fukui; Takashi Yokoo; Masaomi Nangaku; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2019-09-09       Impact factor: 2.801

8.  First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics.

Authors:  Sho Saito; Yusuke Asai; Nobuaki Matsunaga; Kayoko Hayakawa; Mari Terada; Hiroshi Ohtsu; Shinya Tsuzuki; Norio Ohmagari
Journal:  J Infect       Date:  2020-11-02       Impact factor: 6.072

9.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.